Optimizing Chronic Wound Management Outcomes Through Biofilm Based Wound Management: An Expert Panel Discussion

Optimizing Chronic Wound Management Outcomes Through Biofilm Based Wound Management: An Expert Panel Discussion

On-Demand Webcast
Faculty

Jonathan N. Brantley, DPM
Chief Podiatric Medicine & Surgery
McGuire Veteran Affairs Medical Center
Richmond, Virginia

Ryan Fitzgerald, DPM
Clinical Assistant Professor of Surgery
University of South Carolina
School of Medicine, Greenville
GHS Center for Amputation Prevention
Greenville, South Carolina

Greg Schultz, PhD
Professor, Department of Obstetrics and Gynecology
Director, Institute for Wound Research
University of Florida
Gainesville, Florida

TO DOWNLOAD SLIDES CLICK HERE

Intended Learners

This activity is designed for physicians, podiatrists, physical therapists, and nurses involved in the treatment of patients with chronic wounds.

Learning Objects

After completing this activity, participants should be able to:

  • Examine a proactive biofilm‐based wound management (BBWM) strategy aimed at reducing and preventing biofilm re‐formation including the role of surgical debridement
  • Outline properties of an ideal topical antimicrobial for combatting biofilm and explain the science of polyhexamethylene biguanide hydrochloride (PHMB)
  • Assess clinical outcomes of Biofilm Based Wound Management followed by the ideal topical antimicrobial, potentially followed by cellular therapies
  • Explore case studies on the use of surgical debridement, BBWM strategies and proven cellular therapies for the treatment of chronic wounds
Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form.

After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible for credit for this enduring material.

Release Date: May 31, 2018

Expiration Date: May 31, 2019

Estimated time to complete: 60 minutes

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

The evaluation is accessible after the activity via a PC (Windows 7 or newer) or Mac (Mac OS 10.6 or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Accreditation

In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and the Wound Healing Society. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team

CME

NACCME designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE

This continuing nursing education activity awards 1.0 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.

Continuing Podiatric Education

North American Center for Continuing Medical Education, LLC (NACCME) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. NACCME has approved this activity for a maximum of 1.0 continuing education contact hour.

Planning Committee

The planning committee comprises Jonathan N. Brantley, DPM, Daniel Federman, MD, FACP, Ryan Fitzgerald, DPM, Greg Schultz, PhD, Susie Seaman, NP; and Stephanie Kunyz, Tiffney Oliver, Randy Robbin, and Susan Yarbrough, NACCME.

Independent Clinical Reviewer: Daniel Federman, MD, FACP, Professor of Medicine, Yale University School of Medicine, Associate Chief of Medicine, VA Connecticut Healthcare System, West Haven, CT

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Brantley: Speakers’ Bureau – Organogenesis Inc.

Dr. Fitzgerald: Consultant – Organogenesis Inc.; Osiris Therapeutics

Dr. Schultz: Consultant – Medline Industries, Inc., Smith & Nephew, BioMonde, Organogenesis Inc., Lohmann & Rauscher; Grant/Research Support- Organogenesis Inc., CorMedix, Smith & Nephew, Avadim, 3M, Lohmann & Rauscher, BioMonde; Stock Shareholder - QuickMed Technologies

Dr. Federman and Ms. Seaman have disclosed no relevant financial relationships with any commercial interests.

Ms. Kunyz, Ms. Oliver, Mr. Robbin, and Ms. Yarbrough have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed that no off-label/unapproved uses of drugs and/or devises will be discussed in the presentations.

ADA Statement

North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact 609-371-1137.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2018 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Provided by North American Center for Continuing Medical Education, LLC, an HMP Company

Grant Support

Supported by an independent educational grant from Organogenesis Inc.